Martyna Szpakowska

1.6k total citations
54 papers, 972 citations indexed

About

Martyna Szpakowska is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Martyna Szpakowska has authored 54 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 31 papers in Immunology and 25 papers in Molecular Biology. Recurrent topics in Martyna Szpakowska's work include Chemokine receptors and signaling (40 papers), Receptor Mechanisms and Signaling (19 papers) and Immunotherapy and Immune Responses (18 papers). Martyna Szpakowska is often cited by papers focused on Chemokine receptors and signaling (40 papers), Receptor Mechanisms and Signaling (19 papers) and Immunotherapy and Immune Responses (18 papers). Martyna Szpakowska collaborates with scholars based in Luxembourg, Belgium and United States. Martyna Szpakowska's co-authors include Andy Chevigné, Max Meyrath, Julien Hanson, Brian F. Volkman, Andrew B. Kleist, Virginie Fiévez, Jean-Claude Schmit, Markus Ollert, Bassam Janji and Alessandra Baragli and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Martyna Szpakowska

52 papers receiving 970 citations

Peers

Countries citing papers authored by Martyna Szpakowska

Since Specialization

Citations

This map shows the geographic impact of Martyna Szpakowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martyna Szpakowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martyna Szpakowska more than expected).

Fields of papers citing papers by Martyna Szpakowska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martyna Szpakowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martyna Szpakowska. The network helps show where Martyna Szpakowska may publish in the future.

Co-authorship network of co-authors of Martyna Szpakowska

This figure shows the co-authorship network connecting the top 25 collaborators of Martyna Szpakowska. A scholar is included among the top collaborators of Martyna Szpakowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martyna Szpakowska. Martyna Szpakowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840 2025 ·Molecular Pharmacology ·Reggie Bosma, (unknown), (unknown), (unknown), (unknown), Max Meyrath, (unknown), (unknown), Susanne M. A. van der Pol, Iwan J. P. de Esch, Martyna Szpakowska, Maikel Wijtmans, Andy Chevigné, Henry F. Vischer, Rob Leurs	1
2	Design, Synthesis and Pharmacological Characterization of the First Photoswitchable Small-Molecule Agonist for the Atypical Chemokine Receptor 3 2025 ·ACS Omega ·(unknown), (unknown), Francesca Deflorian, Chris de Graaf, (unknown), Martyna Szpakowska, Andy Chevigné, Iwan J. P. de Esch, Barbara Zarzycka, Henry F. Vischer, Maikel Wijtmans, Rob Leurs	0
3	Inclusion of ACKR5 in the systematic nomenclature of atypical chemokine receptors 2025 ·Nature reviews. Immunology ·Martyna Szpakowska, Daniel F. Legler, Stefan Offermanns, Silvano Sozzani, Antal Rot, Marcus Thelen, Andy Chevigné	2
4	Targeting the atypical chemokine receptor 2 ( Ackr2 ) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model 2025 ·OncoImmunology ·Muhammad Zaeem Noman, Martyna Szpakowska, Malina Xiao, Ruize Gao, Kris Van Moer, Akinchan Kumar, Markus Ollert, Guy Berchem, Andy Chevigné, Bassam Janji	0
5	Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization 2024 ·Cell Communication and Signaling ·(unknown), (unknown), Martyna Szpakowska, Andy Chevigné, Dominique Schols, Tom Van Loy	3
6	Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR1 2024 ·ACS Pharmacology & Translational Science ·(unknown), (unknown), (unknown), (unknown), Natalia V. Ortiz Zacarı́as, S. Nasser, Stephan Scholl, Darius P. Zlotos, (unknown), Laura H. Heitman, Martyna Szpakowska, Andy Chevigné, Matthias Schiedel	4
7	Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1 2024 ·ChemMedChem ·(unknown), (unknown), Aurélien F. A. Moumbock, (unknown), Evi Kostenis, (unknown), Martyna Szpakowska, (unknown), Stefan Günther, Finn K. Hansen, Matthias Schiedel	2
8	Conformational selection guides β-arrestin recruitment at a biased G protein–coupled receptor 2022 ·Science ·Andrew B. Kleist, (unknown), Andrija Sente, (unknown), Martyna Szpakowska, Maggie M. Calkins, Emilie I. Anderson, Lisa McNally, Raimond Heukers, Vladimir Bobkov, Francis C. Peterson, Monica A. Thomas, Andy Chevigné, Martine J. Smit, John D. McCorvy, M. Madan Babu, Brian F. Volkman	25
9	Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples 2022 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Max Meyrath, Martyna Szpakowska, (unknown), Olivia Domingues, Jérémie Langlet, Bernard Weber, Rejko Krüger, Markus Ollert, Andy Chevigné	4
10	Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 2022 ·European Journal of Medicinal Chemistry ·(unknown), Carmine Giorgio, (unknown), (unknown), Elisabetta Barocelli, Vigilio Ballabeni, Martyna Szpakowska, Andy Chevigné, Jan Piet van Hamburg, Nadine Davelaar, Erik Lubberts, Simona Bertoni, Marco Radi	15
11	CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis 2020 ·Arteriosclerosis Thrombosis and Vascular Biology ·Osamu Baba, (unknown), Andrew Elvington, Martyna Szpakowska, (unknown), Gyu Seong Heo, Xiaohui Zhang, Hannah Luehmann, Lisa Detering, Andy Chevigné, Yongjian Liu, Gwendalyn J. Randolph	16
12	Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21 2020 ·Biochemistry ·(unknown), Gertrud M. Hjortø, Francis C. Peterson, Martyna Szpakowska, Andy Chevigné, Mette M. Rosenkilde, Brian F. Volkman, Michael B. Dwinell	10
13	CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems 2020 ·Frontiers in Immunology ·(unknown), Paul J. Collins, Mieke Metzemaekers, Max Meyrath, Martyna Szpakowska, (unknown), Sofie Struyf, Paul Proost, Andy Chevigné, Daniel F. Legler, Matthias Eberl, Bernhard Moser	22
14	The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy 2020 ·Advances in cancer research ·Elin Sjöberg, Max Meyrath, Andy Chevigné, Arne Östman, Martin Augsten, Martyna Szpakowska	27
15	The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides 2020 ·Nature Communications ·Max Meyrath, Martyna Szpakowska, (unknown), Laurent Massotte, Myriam P. Merz, Tobias Benkel, Katharina Simon, Jochen Ohnmacht, Jonathan D. Turner, Rejko Krüger, Vincent Seutin, Markus Ollert, Evi Kostenis, Andy Chevigné	82
16	Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds 2019 ·ACS Pharmacology & Translational Science ·Elise Wouters, (unknown), Michael J. Robertson, Max Meyrath, Martyna Szpakowska, Andy Chevigné, Georgios Skiniotis, Christophe P. Stove	49
17	Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists 2018 ·Biochemical Pharmacology ·Martyna Szpakowska, Max Meyrath, (unknown), (unknown), Julien Hanson, Jan Steyaert, Andy Chevigné	28
18	Molecular insights into recognition, activation and function of the atypical chemokine receptor CXCR7/ACKR3 2016 ·Open Repository and Bibliography (University of Liège) ·Martyna Szpakowska	2
19	Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7 2016 ·Biochemical Pharmacology ·Martyna Szpakowska, Nadine Dupuis, Alessandra Baragli, (unknown), Julien Hanson, Jacques Piette, Andy Chevigné	34
20	Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection 2014 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Andy Chevigné, Virginie Fiévez, Martyna Szpakowska, Aurélie Fischer, (unknown), (unknown), Jean-Claude Schmit, (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact